Proinflammatory T helper 17 (Th17) cells control infections caused by microbial pathogens. Surprisingly, several recent reports now reveal that symbiotic gut bacteria modulate Th17 cell differentiation and function in the gastrointestinal tract. As various autoimmune and allergic disorders are mediated by uncontrolled T cell responses, immune regulation by the microbiota may have direct implications for human health.
Immune Responses to Gut Bacteria The mammalian immune system is a remarkable and dynamic organ, responsible for many fundamental aspects of health and disease. Its primary task is to recognize microbial molecules and mount appropriate and specific immune responses. It has been historically viewed that immune reactions to bacteria occur mainly during infections. However, based on more recent work we now know that even normal immune system development depends on specific direction from symbiotic bacteria (Macpherson and Harris, 2004) .
The gastrointestinal tract provides residence to an astounding number of microbial species, which have profound effects on host biology and physiology (Backhed et al., 2005) . Symbiotic bacteria of the mammalian gut have long been appreciated for the benefits they provide to the host, including provision of essential nutrients, metabolism of indigestible compounds, defense against colonization by opportunistic pathogens, and even contributions to the development of the intestinal architecture (Hooper and Gordon, 2001) . Recent studies have shown that symbiotic bacteria synthesize immunomodulatory molecules that guide maturation of the immune system (Mazmanian et al., 2005) ; one result of this interaction is protection from intestinal inflammation (Mazmanian et al., 2008) . Thus, it appears that certain gut bacteria have evolved mechanisms to improve host health by modulating intestinal immune responses.
As a key component of the adaptive immune system, CD4 + T cells are required for vital functions ranging from controlling infectious agents to the regulation of autoimmune reactions and cancers. Effector CD4 + T cells are generally divided into three subtypes: T helper 1 (Th1), Th2, and Th17 (Figure 1 ). These three lineages are responsible for carrying out distinct and opposing activities that are mediated by their unique cytokine repertoires. The proper balance of immunologic responses between T helper subsets has been shown to be critical to the overall health of humans and animals (Steinman, 2007) . For example, elevated proportions of Th1/Th17 cells lead to inflammatory bowel disease and autoimmunity (e.g., multiple sclerosis, rheumatoid arthritis, psoriasis), while increased expression of Th2 cytokines is associated with asthma and other allergic disorders. Whereas Th1 and Th2 cells have been studied for about two decades, Th17 cells that produce the potent inflammatory cytokine interleukin-17 (IL-17) have been identified in only the last few years (Bettelli et al., 2006; Weaver et al., 2007) . Now, a series of recent reports suggest that the differentiation of intestinal Th17 cells and their balance with anti-inflammatory regulatory T cells (Tregs) critically depends on the intestinal microbiota ( Figure 1 ). Based on the involvement of Th17 cells in various inflammatory conditions, understanding how and more importantly why gut bacteria influence this specific T cell lineage may have significant implications for human health.
The Microbiota Shape Intestinal Th17 Cell Development IL-17 production is controlled by the orphan nuclear receptor RORgt (retinoic acid-related orphan receptor), widely considered the ''master regulator'' of Th17 cell differentiation (Ivanov et al., 2006) . Using an RORgt-GFP reporter mouse, Littman and colleagues demonstrate that IL-17-expressing CD4 + T cells are preferentially enriched in the small intestinal lamina propria relative to other tissues (Ivanov et al., 2008) . Though several other sites did contain RORgt + cells, the vast majority of nonintestinal IL-17-producing cells were not TCRab + CD4 + T cells, indicating that most ''classical'' Th17 cells are in the gut. In order to understand the timeframe for Th17 cell development, the authors measured IL-17 expression from various stages during ontogeny. IL-17 production from CD4 + T cells of the small intestine was absent from newborn mice, but steadily increased from birth to postweaning. As mammals are born sterile and subsequently initiated into an organized program of colonization by symbiotic bacteria (Palmer et al., 2007) , could it be possible that the intestinal microbiota plays a role in Th17 cell development?
Over four decades of germ-free (GF) animal research have shown that genetically wild-type animals display numerous defects in both cellular and morphologic development of the immune system in the absence of microbiota (reviewed in Macpherson and Harris [2004] ). Ivanov et al. explored the hypothesis that microbial colonization after birth induces the generation of intestinal Th17 cells by first examining IL-17 production by CD4 + T cells in GF animals. Surprisingly, animals devoid of microbial (bacterial, viral, fungal, and protozoan) colonization were dramatically deficient in the production of IL-17 from TCRb + CD4 + cells of the small intestinal lamina propria (Ivanov et al., 2008) .
Only a minor defect in IL-17 production was noted for gd T cells, suggesting that the lack of Th17 cells was not due to an overall deficiency in immune activation, and that specific features of the immune response are sensitive to the microbiota. Moreover, TCRb + Th17 cells from lamina propria lymphocytes (LPLs) appear to represent the major source of IL-17, as levels of the Il17 transcript are greatly reduced in GF intestines compared to those of colonized animals. When GF animals were reconstituted with the microbiota of SPF (specific pathogen-free) animals, IL-17 production in the small intestine returned as the proportions of Th17 cells increased gradually over several weeks. In contrast to the finding that GF animals are deficient in intestinal IL-17 expression, Zaph et al. observed equivalent proportions of IL-17 + CD4 + T cells in the small intestine of GF animals (Zaph et al., 2008) . The basis for the discrepancies appears enigmatic, as animal strains, housing conditions, and experimental approaches seem to be comparable between studies. However collectively, it appears that the microbiota modulates steadystate immune responses by either positively or negatively influencing Th17 cell development. The finding that intestinal microbes modulate IL-17 expression by intestinal CD4 + T cells represents an important aspect of T helper cell biology that was previously unappreciated.
Subsets of Bacterial Populations Affect T Helper Profiles
The identity of bacterial species that modulate ''homeostatic'' IL-17 production is currently unknown, but Ivanov et al. have begun to address this issue based on a very intriguing observation. SPF mice from Jackson Laboratory display greatly reduced percentages of IL-17 + T cells compared to SPF mice from Taconic Farms, even though the genotypes are identical (Ivanov et al., 2008) . When animals from each vendor were cohoused, the proportions of Th17 cells among small intestinal LPLs of Jackson Laboratory mice were restored. As SPF mice from each source contain diverse but different microbiotas, this argues that particular subsets of bacteria are specifically involved in IL-17 production and that IL-17 production is not a result of general bacterial colonization. In support of this notion, transplantation of gut bacteria from Taconic mice into GF recipients restored their defect in Th17 cell numbers, whereas bacteria from Jackson Laboratory mice did not. The microbiome of both mice and man are dominated by two phyla (over 90% belong to either Bacteroidetes or Firmicutes) (Ley et al., 2008) . Molecular analysis indicated that Jackson mice were not colonized with Bacteroidetes (formerly known as Cytophaga-Flavobacteria-Bacteroides [CFB]), and treatment with antibiotics that reduced Bacteroidetes colonization in Taconic mice led to a reduction in IL-17 production by CD4 + T cells. These studies suggest a profound hypothesis: Th17 cell differentiation is directed by specific classes of bacteria in a dynamic and reversible manner. If true, then alterations in the microbial community could alter IL-17 production in the gut, having significant implications for intestinal (and perhaps nonintestinal) inflammatory diseases.
Potential Mechanisms by which Bacteria Modulate Gut Immune Profiles
The mechanism of microbiota-mediated Th17 cell differentiation was recently addressed by Takeda and colleagues, who reported that adenosine 5 0 -triphosphate (ATP) is sufficient to increase IL-17 production from CD4 + T cells (Atarashi et al., 2008) . Investigating T helper cell phenotypes among LPLs of the colon, Atarashi et al. revealed that GF animals display a reduction in colonic IL-17 levels and fecal ATP concentrations. They also show that intestinal bacteria secrete copious amounts of ATP. Signaling through ATP sensors, long known to be involved in enteric nervous system function, has recently been shown to induce the expression of IL-23 from dendritic cells (Schnurr et al., 2005) . As IL-23 is involved in the expansion and maintenance of the Th17 cell lineage, the authors speculated that ATP produced by the microbiota may be critical for IL-17 expression by intestinal , and function to control infections by intracellular pathogens (i.e., viruses and bacteria). Th2 cells secrete IL-4, IL-5, and IL-13, and mediate immune responses to extracellular pathogens (i.e., parasites and bacteria). Th17 cells secrete IL-17, IL-21, and/or IL-22, and are believed to respond following infection by extracellular pathogens (i.e., fungi and bacteria). However, proinflammatory immune responses need to be regulated, as uncontrolled or elevated reactions will result in collateral damage to host tissues. Increased and prolonged Th1/ Th17 responses are believed to drive autoimmune diseases such as multiple sclerosis, type 1 diabetes, rheumatoid arthritis, and psoriasis. Th2 responses, when left unchecked, may underlie the development of asthma and several allergic disorders. Proinflammatory immune reactions are controlled by regulatory T cells, which secrete factors such as IL-10 and TGFb, and through other mechanisms that are still not well defined, limit T helper responses either following pathogen clearance or during the steady state. The current view of T helper differentiation posits that each of these lineages is distinct, and defined by gene regulatory networks encoded by the mammalian genome during T cell development. Recent studies are now suggesting that the distinction between each lineage fate is not predetermined, and may be adaptable. For example, the ratios between Th17 and Treg cell differentiation in the colon may be influenced by the intestinal microbiota, perhaps through modulation of their respective transcription factors, RORgt and Foxp3. Therefore, improper modulation of the balance between pro-and anti-inflammatory cell responses can lead to immune disorders, potentially linking the microbiota to noninfectious diseases.
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Cell Host & Microbe CD4 + T cells. Indeed, either rectal or intraperitoneal administration of ATP to GF mice resulted in an increase in Th17 proportions, and treatment of SPF mice with apyrase (which cleaves ATP) led to a decrease in the percentages of IL-17-producing CD4 + T cells in colonic LPLs. It is intriguing that intraperitoneal injection of ATP led to an increase in colonic IL-17 levels and raises questions regarding tissue specificity (Were other anatomical locations also affected by systemic ATP treatment? Does ATP influence lymphocyte homing to the gut?). However, cytokine responses seem to be specific. Although GF animals are reduced in interferon-g (IFNg) production, ATP did not affect the expression of IFNg, which is the canonical cytokine produced by Th1 cells. These observations suggest that different molecular signals (possibly produced by distinct members of the microbiota) mediate differential T helper cell phenotypes during intestinal colonization. A recent study similarly reported that gut bacteria mediate IL-17 and IFNg production in the colon, though the role of ATP was not investigated (Niess et al., 2008) . Consistent with the notion that ATP may be acting on intestinal dendritic cells (DCs), conditioned media from cultures of intestinal bacteria (but not pathogenic bacteria) was able to induce IL-17 production by CD4 + T cells during in vitro CD11c + DC-T cell cocultures. Treatment of the conditioned media with apyrase abolished this activity, strongly suggesting that ATP, and not another bacterially produced factor, is required for Th17 cell differentiation. The same conditioned media that induced IL-17 expression did not increase IFNg levels in the coculture system, demonstrating that ATP does not affect the differentiation of T H 1 cells. Using an antibiotic treatment regimen to target specific classes of bacteria, Atarashi et al. also show that fecal ATP concentrations are lowered along with Th17 cell proportions. Collectively, these findings imply that specific members of the microbiota may preferentially produce ATP, which ultimately promotes IL-17 expression in the colon of experimental animals.
The intestinal symbiotic bacteria are separated from the gutassociated lymphoid tissues (GALT) by a single layer of intestinal epithelial cells. Correspondingly, epithelial cell responses to nonpathogenic gut bacteria may impact the nature and development of intestinal immune responses. Artis and colleagues recently investigated the contributions of the microbiota on intestinal epithelial cell (IEC) regulation of Th17 development (Zaph et al., 2008) . Their studies indicate that the proportions of colonic (and cecal patch) Th17 cells were elevated in GF animals compared to SPF animals, which displayed nominal levels of IL-17. This finding was consistent in at least two strains of mice (C57BL/6 and BALB/c). Zaph et al. further show that levels of IL-23, in addition to those of IL-17, are increased in colonic tissues of GF mice. As IL-23 is known to be required for maintenance of the Th17 phenotype, the authors speculate that inhibition of IL-23 expression by the microbiota reduces IL-17 production. Accordingly, the IECs of GF animals are deficient in the expression of IL-25, a known inhibitor of IL-23. Treatment of GF mice with IL-25 reduced IL-17 and IL-23 expression in the colon, whereas IL-25 À/À animals displayed increased IL-17 and IL-23 levels. Although we do not know the identity of the IL-25-inducing microorganism(s), these data suggest that the microbiota may signal through IECs to regulate the development of colonic T H 17 cells. Though an extensive analysis is beyond the scope of this review, the role of epithelial cells in mediating ''communication'' between the microbiota and the innate and adaptive immune system is an emerging and exciting field of research.
Regulatory T Cells Respond to Microbial Products to Balance T Helper Responses
A healthy immune system is designed to balance inflammatory responses with suppressive mechanisms to limit collateral damage to tissues. Many studies have identified a reciprocal relationship between inflammation mediated by T helper cells and anti-inflammatory regulatory T cell (Treg) responses (Bettelli et al., 2006) . Foxp3 (forkhead box P3) is a Treg lineage specific transcription factor that can induce regulatory phenotypes and immunosuppressive functions by CD4 + T cells (Fontenot et al., 2005) . Defects in Foxp3 Treg activity (such as by mutations in the foxp3 gene) cause severe multiorgan lymphoproliferative disease in both humans and animals (Foussat et al., 2003) . Previous studies have identified a critical role for Foxp3 + Tregs in controlling intestinal inflammation, and Ivanov et al. report that Tregs are proportionally increased in LPLs of GF animals (simultaneous with a decrease in Th17 cells) (Ivanov et al., 2008) . Accordingly, Belkaid and colleagues investigated if microbiota influence the equilibrium between effector T cells and regulatory T cells in the gut. Toll-like receptors (TLRs) are well known to modulate intestinal inflammation, and TLR9 signaling can limit Treg suppression. The authors observed that Tlr9 À/À animals (reared under SPF conditions) contained increased proportions of Foxp3 + T cells in various gut tissues, most notably in the lamina propria of the small intestine (Hall et al., 2008) . Concomitantly, the levels of IFNg and IL-17 were markedly decreased among CD4 + T cells of Tlr9 À/À animals in multiple intestinal tissues. Thus, signaling through TLR9 appears to reciprocally modulate the equilibrium between effector T cells and regulatory T cells. Hall et al. go on to show that engagement of TLR9 with the model ligand CpG (a microbial DNA mimic) inhibits naive T cell differentiation into Tregs, and the same effect is observed with DNA extracted from intestinal microbes. Furthermore, cells from Tlr9 À/À animals did not respond to gut bacterial DNA. The authors suggest that intestinal bacteria may be involved in suppressing Treg cell conversion, and that the absence of TLR9 limits inflammatory responses due to a defect in ''sensing'' the microbiota. A role for the microbiota in mediating this process was demonstrated when administration of antibiotics resulted in reduced Th1 and Th17 cytokine responses, similar to that observed in Tlr9 À/À animals. Gut bacterial DNA given to antibiotic-treated mice restored the levels of IFNg and IL-17, suggesting that DNA from the microbiota functions as an adjuvant to increase homeostatic levels of inflammatory cytokines. The findings that gut bacteria induce controlled, homeostatic inflammation may have important consequences, as a mucosal immune system that is ''primed'' by the microbiota may be able to respond more quickly to pathogenic infections. Though the specificity of the DNA is still uncertain (for example, will DNA from microbial communities outside the gut have the same effect?), and the mechanism by which DNA inhibits Treg conversion is not fully known, Hall et al. provide interesting potential functions for gut bacteria in modulating intestinal immune responses.
Regulation of Intestinal Th17 Responses by the Microbiota during Experimental Disease
A ''balanced'' equilibrium among T helper cell responses is required for many aspects of immunologic health. Imbalances in the composition of the bacterial microbiota, known as dysbiosis, are postulated to be a major factor in human disorders such as inflammatory bowel disease (IBD). To address the impact of IL-17 production by the microbiota for health, Takeda and colleagues show that the administration of ATP during the induction of intestinal inflammation results in increased pathology and severity of disease (Atarashi et al., 2008) . Using an experimental model of colitis whereby T cells are transferred into severe combined immunodeficient (SCID) mice, it was shown that ATP injections led to a specific increase in Th17 cells. This increase coincided with exacerbation of disease symptoms, including increases in inflammatory cell infiltration into colonic tissues, epithelial hyperplasia, and weight loss. However, it must be considered that the T cell transfer model was performed in SPF animals, which are known to develop disease as a consequence of uncontrolled immune reactions directed toward the resident microbiota. Thus, as expected, ATP administration augmented the disease process by elevating Th17 responses. As noted by the authors, this experimental approach does not test the homeostatic function of microbiota-mediated IL-17 production. GF recipient animals do not develop disease when the same T cells are transferred, and so the biological role for ATP during Th17 differentiation may be better revealed in the absence of inflammation induced toward SPF bacteria. As IL-17 is known to be involved in protection from extracellular pathogens, challenge of GF mice with enteric pathogens in the presence or absence of ATP may help assign a possible function to Th17 cell differentiation in the gastrointestinal tract.
Though not working in a GF system, Hall et al. explored the potential that signals from the microbiota may help protect animals from microbial infections. After showing that antibiotic treatment of mice led to a decrease in intestinal IL-17 production (similar to Tlr9 À/À animals), and that DNA from intestinal bacteria was sufficient to correct this defect, the authors speculated that a reduction in IL-17 may impair immune responses that control intestinal infections (Hall et al., 2008) . Infection of antibiotic treated animals with Encephalitozoon cuniculi, a microsporidial pathogen that causes severe diarrhea in immunocompromised people, resulted in an increase in parasite infectivity. Therefore, similar to studies done in GF mice (Macpherson and Harris, 2004) , the microbiota appears to limit enteric infections. More importantly, administration of gut microbiota DNA to animals with antibiotics provided protection from E. cuniculi infections, suggesting that homeostatic restoration of IL-17 levels provides a health benefit to the host. A control TLR ligand (lipopolysaccharide; LPS) did not reduce parasite burden, indicating the specificity of DNA for this process. Therefore, it appears that a reduction in IL-17 levels (either in GF or antibiotic-treated animals) may cause immunologic deficiencies and increased susceptibility to pathogenic infections. These studies bring to light a new perspective of the microbiota-induction of ''regulated'' inflammatory processes by gut bacteria may be a means of actively shaping beneficial immune responses, as opposed to pathogens which induce acute inflammation to promote the disease process.
Conclusion
The human gastrointestinal tract is home to a complex microbial ecosystem that contains 10-fold more cells than the human body, encodes for 100 times the number of genes in the human genome, and possesses the metabolic capacity of the human liver. Though millions of years of coevolution have forged the potential for host-bacterial symbiosis, the influence of this ''forgotten organ'' on our biology and health is only now being truly appreciated. Based on clinical, epidemiologic, and immunologic evidence, it appears that changes in the intestinal microbiota may be an essential factor in numerous inflammatory disorders. Accordingly, a recent series of articles is beginning to highlight the importance of balancing both the effector and regulatory arms of the intestinal immune response. These studies show that the microbiota influences proinflammatory Th17 cell differentiation through molecular pathways that may include bacterial DNA, ATP, and signaling through IECs. Several reports, not described here, have recently revealed that intestinal bacteria also induce Treg development and function (though the molecular mechanisms remain a mystery). Collectively, emerging evidence indicates that a healthy microbiota mediates overall ''balance'' in the immune system, as opposed to strictly driving pro-or anti-inflammatory responses. How the microbiota does so is most likely a function of the community structure-i.e., the microbiota is not a single entity, but an amalgam of diverse microorganisms with distinct roles. Some organisms may drive Treg development specifically, while others only promote Th17 development. Though Th17 cells are required for clearance of extracellular pathogens, excessive levels of IL-17 are implicated in diseases such as multiple sclerosis, IBD, psoriasis, lupus, and rheumatoid arthritis. Therefore, depletion of Treg promoting organisms and/or overgrowth of microbes that drive Th17 development may result in a proinflammatory immune profile. Factors that change the composition of the microbiota (pervasive antibiotic use, hygiene, high-calorie diets, vaccinations, etc.) could alter healthy microbial balances resulting in inflammatory disorders. As Aristotle wrote, ''True virtue lies in moderation.'' Perhaps immunologic virtue is lost during dysbiosis, adversely tipping the balance toward exacerbated inflammation that results in disease. As the mammalian immune system evolved in the presence of symbiotic microbes (i.e., mammals were never germ free), it is very conceivable that some microbes actively network with the immune system to regulate specific host responses. If true, then we may have to contemplate the possibility that the human genome does not encode all functions required for health, and that we depend on crucial interactions with the human microbiome for our wellbeing.
